Recent Insights » Articles » Q&A with Dr. Nathaniel Katz
   

Q&A with Dr. Nathaniel Katz

April 16, 2019

Dr. Katz, Chief Science Officer and the founder of Analgesic Solutions, shared his insights during a recent conversation with Mark Opler, MD, PhD, Chief Research Officer at WCG’s MedAvante-ProPhase. WCG recently acquired Analgesic Solutions.

Previous Flipbook
Q&A: The Role of Expert Committees and the Regulatory Landscape
Q&A: The Role of Expert Committees and the Regulatory Landscape

Dr. Seltzer, president and founder of ACI Clinical, and chief scientific officer of WCG Clinical, shared hi...

Next Flipbook
Optimizing SUSAR distribution in a connected– but unharmonized–world
Optimizing SUSAR distribution in a connected– but unharmonized–world

Steven Beales and Joe O’Rourke, vice president, business development talk through some of the difficulties ...

Request a Genetics in Clinical Trials training session

What You'll Learn
Return to Home